Can A Blood Test Detect Melanoma? | What It Can Tell You

A blood draw can’t confirm melanoma by itself, but a few lab results can help track known disease and plan what comes next.

When you’re worried about melanoma, a blood test sounds like the cleanest answer on earth. One needle, one report, done. The reality is messier. Melanoma usually has to be seen and sampled where it starts: in the skin.

Doctors still diagnose melanoma by examining the spot and taking a biopsy so the cells can be reviewed under a microscope. That’s the step that can label a lesion as melanoma and report details that shape treatment. The American Cancer Society describes biopsy as the test that confirms melanoma. Tests for melanoma skin cancer walks through that process.

Blood tests still matter in melanoma care. They just have a different job: they can add context once melanoma is already suspected or confirmed, especially in later-stage disease. Think of bloodwork as a signal light, not a verdict.

What Blood Tests Can Show In Melanoma Care

Most bloodwork ordered around melanoma falls into two buckets: routine panels that show how your body is doing, and a small set of markers that can relate to advanced melanoma.

Routine Panels That Set A Baseline

Common labs like a complete blood count (CBC) and a comprehensive metabolic panel (CMP) don’t diagnose melanoma. They can still be useful before surgery, scans with contrast, or systemic therapy. They flag things like anemia, infection, kidney strain, or liver strain so a team can plan safely.

Markers That May Track Later-Stage Disease

A few markers can shift in metastatic melanoma. The catch is simple: they’re not specific to melanoma. They can also move with many non-cancer conditions. That’s why these labs are usually read alongside imaging, symptoms, and the full clinical picture.

Why A Biopsy Still Matters Most

A biopsy can do what blood can’t. It can show whether the cells are melanoma, how deep they go, whether there’s ulceration, and whether margins are clear after removal. Those details drive staging and treatment decisions.

Blood can’t report Breslow thickness. It can’t tell whether a lesion is melanoma or a harmless nevus. Early melanoma may also shed very little into the bloodstream, so even newer blood-based approaches can miss it when it’s small.

When Bloodwork Shows Up During Diagnosis And Staging

Blood tests may be ordered at these points:

• Before a procedure: Baseline labs help teams plan anesthesia, surgery, or scan contrast.
• When melanoma is confirmed: Some stages prompt imaging and labs to check for spread and to establish a baseline before treatment.
• During treatment: Many drugs can affect the liver, kidneys, thyroid, or blood counts, so labs help spot side effects early.

The National Cancer Institute’s clinician summary lays out melanoma staging and treatment pathways and notes prognostic factors used in later-stage disease. Melanoma treatment (PDQ®) is a solid reference for what’s used in practice.

Lactate Dehydrogenase And Why It’s Ordered

LDH (lactate dehydrogenase) is the melanoma blood test marker people hear about most. LDH is an enzyme released when cells break down. In stage IV melanoma, higher LDH can line up with higher tumor burden and worse outcomes. It’s commonly used as a prognostic marker in metastatic melanoma.

Still, LDH isn’t a melanoma detector. It can rise with infection, liver disease, intense exercise, heart injury, and many other problems. A high LDH is a reason to look closer, not a label on its own.

The NCI SEER staging data definitions describe LDH as a serum marker used in stage IV melanoma and note it reflects cell damage and possible tumor burden. LDH lab value for melanoma skin explains how it’s handled in staging data systems.

Other Blood Markers And Newer Blood-Based Tests

Beyond LDH, you may hear about other markers and “liquid biopsy” tests. Some are used in selected clinics. Some are mostly research tools. A few quick notes can keep you grounded.

S100B

S100B is a protein that can rise in melanoma, often in more advanced disease. It can also rise with brain injury and other conditions. When it’s used, trends over time may matter more than one reading.

Circulating Tumor DNA

Circulating tumor DNA (ctDNA) tests look for tumor-related DNA fragments in blood. In melanoma, ctDNA is being studied for monitoring treatment response and for spotting early recurrence after treatment in selected settings. It’s not a routine screening test for people with a new mole, because early melanoma may not shed enough DNA into blood to detect reliably.

Blood Tests For Melanoma Monitoring And Staging

This table sums up what each test can do, and where it can mislead you if it’s treated like a yes-or-no diagnosis tool.

Test Or Marker	What It Can Tell You	Where It Falls Short
Skin biopsy (tissue)	Confirms melanoma and reports tumor features	Requires a procedure; still needed for diagnosis
CBC	Baseline blood counts; treatment safety checks	Not melanoma-specific
CMP	Liver/kidney function; scan and drug safety	Changes have many causes
LDH	Prognosis and trend tracking in metastatic disease	Often elevated for non-cancer reasons
S100B	May help monitor advanced disease in selected settings	Not used everywhere; not specific
ctDNA	May track treatment response or early recurrence in selected settings	Not standard screening; needs enough tumor DNA present
Thyroid markers (TSH, free T4)	Checks for therapy-related thyroid changes	Doesn’t diagnose melanoma
Inflammation markers (like CRP)	Can add context during symptom workups	Very non-specific

Can A Blood Test Detect Melanoma? What Doctors Use Instead

If your worry is a changing mole, the fastest path to a clear answer is still skin-first care. Here’s what that usually looks like.

Skin Exam With A Dermatoscope

A clinician checks the spot and the rest of your skin, often using a dermatoscope to see patterns not visible to the naked eye. They’ll ask about change over time, sun exposure history, and family history.

Biopsy Of The Spot

A biopsy removes part or all of the lesion so a pathologist can confirm what it is. This is where melanoma is ruled in or ruled out.

Staging Steps If Needed

If the melanoma is thick, ulcerated, or linked to lymph node findings, staging can involve sentinel lymph node biopsy, imaging, and labs. Blood tests can add context, but they don’t replace tissue diagnosis.

How To Judge “Melanoma Blood Test” Claims

Some online claims blur routine bloodwork with advanced molecular tests. Use this table to keep your footing before you spend money or skip proven care.

Claim You May See	What To Ask Yourself	Safer Next Move
“Detects melanoma early”	Is it validated for early melanoma, or only for known cancer monitoring?	Book a skin exam and biopsy of suspicious spots
“No biopsy needed”	How does it confirm melanoma and report tumor details without tissue?	Don’t skip pathology
“Negative means you’re clear”	Does the company list false-negative rates for melanoma?	Treat symptoms and skin changes as the trigger for evaluation
“High marker proves melanoma”	Could the marker rise from other conditions?	Pair labs with exam and imaging
“Works for everyone”	Does it target a known tumor mutation or a broad signal?	Ask what population it was tested in
“Perfect for screening”	Does it show real-world benefit, not just detection?	Stick with skin checks and prompt biopsy
“Clinically proven”	Is there peer-reviewed evidence and clear intended use?	Ask your clinician how it fits your stage and plan

What To Do If You’re Worried Today

If you’ve got a new or changing lesion, don’t wait on bloodwork. Schedule a skin exam. If a biopsy is recommended, get it done. That’s the route that answers the question you actually care about: “Is this melanoma?”

If you already have melanoma and you’re tracking labs, ask what each test is meant to track and what change would trigger imaging or a visit. It’s easier to breathe when you know the plan tied to the numbers.